An elevated PSA indicates that the prostate should be evaluated more closely, but it is not a cancer diagnosis: it can also rise due to benign enlargement, inflammation, or infection2,3. After an initial high result, guidelines from the American Urological Association and the Society of Urologic Oncology (AUA/SUO) recommend repeating the test before moving on to further studies1. Depending on the result and your risk, the next step may be an MRI and, only if indicated, a biopsy1,4.
Why Can PSA Rise Without Cancer?
Prostate-specific antigen (PSA) is produced by both healthy and diseased prostate tissue, which is why several benign conditions can cause it to rise2,3:
| Cause | Why it raises PSA | Typical next step |
|---|---|---|
| Benign prostatic enlargement | A larger prostate produces more PSA | Measure prostate size and interpret PSA relative to volume |
| Prostatitis (prostate inflammation) | Inflammation releases more PSA into the bloodstream | Evaluate and treat the cause; recheck PSA afterward |
| Urinary tract infection | Infection can irritate the prostate | Treat the infection and repeat testing as indicated |
| Recent urinary tract procedures | Prostate manipulation can temporarily skew the value | Inform your doctor to interpret the result accurately |
Also be sure to inform your urologist if you take medications for prostate enlargement from the 5-alpha reductase inhibitor class (finasteride, dutasteride), as they lower PSA levels, which must be accounted for during interpretation1.
Why Is PSA Retested Before Making a Decision?
PSA levels can fluctuate from one test to another. For this reason, after an initial elevated result, the AUA/SUO guideline recommends repeating the test before ordering biomarkers, an MRI, or a biopsy1. If a temporary cause was present, such as an infection, your urologist may advise waiting until it resolves before retesting.
The result is never interpreted in isolation: your age, prostate size, family history, and trends over time from previous measurements are all taken into account1,2.
What Is the Purpose of a Prostate MRI?
If PSA remains elevated, a multiparametric MRI can identify suspicious areas within the prostate1,4. European guidelines (EAU) recommend performing it before a biopsy, as it helps determine whether a biopsy is truly necessary and guides the needles toward higher-suspicion areas4. In addition to MRI, the AUA/SUO guideline considers blood or urine biomarkers to refine risk assessment in select patients1.
When Is a Prostate Biopsy Indicated?
Only a biopsy can confirm cancer, as it involves tissue analysis. Generally speaking, it is considered when1,4:
- PSA remains elevated upon retesting and the MRI shows a suspicious lesion.
- There are abnormal findings on physical examination.
- The estimated risk is high based on your history, even if the MRI does not show an overtly suspicious area.
In certain men with low suspicion and an MRI without significant findings, deferring the biopsy and maintaining PSA surveillance may be considered4. This decision is made together with your urologist.
Frequently Asked Questions
What is a normal PSA level?
There is no single cutoff value that applies equally to every man. PSA is interpreted alongside age, prostate size, family history, and trends from prior tests1,2. For this reason, it is best for a urologist to assess your result in context rather than relying solely on the laboratory reference range.
Can I get a PSA test if I have a urinary tract infection?
A urinary tract infection or prostate inflammation can temporarily raise PSA levels2,3. If you have burning or fever, let your doctor know: they may recommend treating the infection first and rechecking PSA later, so the result more accurately reflects the state of your prostate.
If you received a high PSA result, Dr. Manuel Alejandro González Ramírez, specialist in Urology, Endourology, and Robotic Surgery at CURO, Centro Urológico de Occidente, can review your results and explain the next steps. Read the comprehensive guide on prostate checkups and the PSA test or learn more about having a prostate checkup in Guadalajara.
References
- Wei JT, Barocas DA, Carlsson S, et al. Early Detection of Prostate Cancer: AUA/SUO Guideline Part I: Prostate Cancer Screening. American Urological Association; julio de 2023.
- Pinsky PF, Parnes H. Screening for Prostate Cancer. New England Journal of Medicine. 13 de abril de 2023.
- Xu, McPharlin, Mulhem. Prostate Cancer Screening: Common Questions and Answers. American Family Physician. Noviembre de 2024.
- Cornford P, van den Bergh RCN, Briers E, et al. EAU-EANM-ESTRO-ESUR-ISUP-SIOG Guidelines on Prostate Cancer—2026 Update. Part I: Screening, Diagnosis, and Local Treatment With Curative Intent. European Urology. 1 de septiembre de 2026.
